FDA NDC Directory · JSON-LD · Markdown

Griseofulvin

NDC 0713-0850 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Labeler / ManufacturerCosette Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA065438
Dosage form / routeSUSPENSION · ORAL
Active ingredientsGRISEOFULVIN (125 mg/5mL)
Marketing started20221101
Package count1

External sources

Source: openFDA. Public-domain (CC0).